TCI Wealth Advisors, Inc. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$13,298
+19.0%
802
+33.4%
0.00%0.0%
Q4 2022$11,179
+39.7%
6010.0%0.00%
+100.0%
Q3 2022$8,000
+100.0%
6010.0%0.00%0.0%
Q2 2022$4,000
-20.0%
6010.0%0.00%0.0%
Q1 2022$5,000
+25.0%
6010.0%0.00%0.0%
Q4 2021$4,0006010.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders